0001209191-16-130131.txt : 20160629
0001209191-16-130131.hdr.sgml : 20160629
20160629194142
ACCESSION NUMBER: 0001209191-16-130131
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160627
FILED AS OF DATE: 20160629
DATE AS OF CHANGE: 20160629
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SPECTRUM PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000831547
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 930979187
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11500 S. EASTERN AVE., SUITE 240
CITY: HENDERSON
STATE: NV
ZIP: 89052
BUSINESS PHONE: 702-835-6300
MAIL ADDRESS:
STREET 1: 11500 S. EASTERN AVE., SUITE 240
CITY: HENDERSON
STATE: NV
ZIP: 89052
FORMER COMPANY:
FORMER CONFORMED NAME: NEOTHERAPEUTICS INC
DATE OF NAME CHANGE: 19960819
FORMER COMPANY:
FORMER CONFORMED NAME: AMERICUS FUNDING CORP
DATE OF NAME CHANGE: 19920703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: COHEN RAYMOND W
CENTRAL INDEX KEY: 0001258288
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35006
FILM NUMBER: 161740129
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-06-27
0
0000831547
SPECTRUM PHARMACEUTICALS INC
SPPI
0001258288
COHEN RAYMOND W
11500 S. EASTERN AVE., SUITE 240
HENDERSON
NV
89052
1
0
0
0
Common Stock, $0.001 par value
2016-06-27
4
F
0
625
6.47
D
28750
D
Common Stock, $0.001 par value
2016-06-28
4
F
0
2500
6.33
D
26250
D
Common Stock, $0.001 par value
2016-06-28
4
A
0
10000
0.00
A
36250
D
Stock Option (Right to Buy)
6.33
2016-06-28
4
A
0
20000
0.00
A
2026-06-28
Common Stock
20000
20000
D
Represents restricted shares withheld by Spectrum to satisfy Reporting Person's tax withholding obligations. The shares have not been sold by the Reporting Person or by Spectrum. The shares have been cancelled by the transfer agent.
100% of the restricted shares shall vest on the earlier of (1) June 28, 2017 or (2) the date of the company's 2017 Annual Meeting of Shareholders.
25% of the option shares vested on June 28, 2016. The remaining option shares shall vest in 25% equal annual amounts on each anniversary date of the grant over three years.
/s/ Kurt A. Gustafson, attorney-in-fact for Raymond W. Cohen
2016-06-29